Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL8630437 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TDP1 | |
| Water SCHEMBL5956965 | 1.00 | ALDH1A1 (0.32) | ALDH1A1TDP1 | |
| SCHEMBL6998232 | 0.98 | ALDH1A1 (0.33) | ALDH1A1TDP1 | |
| SCHEMBL11373390 | 0.95 | ALDH1A1 (0.32) | ALDH1A1TDP1 | |
| SCHEMBL11285906 | 0.95 | ALDH1A1 (0.32) | ALDH1A1TDP1 | |
| Lithium Ion SCHEMBL28830259 | 0.95 | ALDH1A1 (0.32) | ALDH1A1TDP1 | |
| SCHEMBL7622902 | 0.82 | — | — | |
| Lithium Ion SCHEMBL31235405 | 0.81 | LMNA (0.32) | ALDH1A1TDP1 | |
| SCHEMBL733409 | 0.77 | ALDH1A1 (0.43) | ALDH1A1TDP1 | |
| SCHEMBL29285237 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5665802-A | REACTING POLYAMIC ACID WITH A DEHYDRATION-CYCLIZATION AGENT, A CATALYST AND AN ORGANIC PHOSPHORUS COMPOUND; EXCELLENT IN TENSILE STRENGTH AND FLEXIBILITY | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1997-09-09 | — | — | US | claimed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | claimed |
| US-20160030321-A1 | CALCIUM SEQUESTRATION COMPOSITIONS AND METHODS OF TREATING SKIN PIGMENTATION DISORDERS AND CONDITIONS | NEOCUITIS S A (CH) | 2016-02-04 | — | — | US | disclosed |
| EP-1161436-B1 | Polyunsaturated fatty acid derivatives and their use in the treatment of cancer | ARDENIA INVESTMENTS LTD (GI) | 2003-06-25 | — | — | EP | disclosed |
| US-6403554-B2 | Polyunsaturated fatty acid derivatives and their use | ARDENIA INVESTMENTS LTD. (GI) | 2002-06-11 | — | — | US | disclosed |
| EP-1161436-A1 | POLYUNSATURATED FATTY ACID DERIVATIVES AND THEIR USE | Ardenia Investments Ltd. (GI) | 2001-12-12 | — | — | EP | disclosed |
| US-20010037032-A1 | Polyunsaturated fatty acid derivatives and their use | OASMIA PHARMACEUTICAL AB (SE) | 2001-11-01 | — | — | US | disclosed |
| US-6274747-B1 | COMPOUNDS CONTAINING A PHOSPHATE GROUP AND SECONDARY AMIDE GROUP; ANTICANCER AGENTS | ARDENIA INVESTMENTS LTD. (GI) | 2001-08-14 | — | — | US | disclosed |
| WO-2000047589-A1 | POLYUNSATURATED FATTY ACID DERIVATIVES AND THEIR USE | ARDENIA INVESTMENTS LTD. (SE) | 2000-08-17 | — | — | WO | disclosed |
| US-5665802-A | REACTING POLYAMIC ACID WITH A DEHYDRATION-CYCLIZATION AGENT, A CATALYST AND AN ORGANIC PHOSPHORUS COMPOUND; EXCELLENT IN TENSILE STRENGTH AND FLEXIBILITY | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1997-09-09 | — | — | US | disclosed |
| US-5500668-A | INK JET PRINTING | XEROX CORPORATION (US) | 1996-03-19 | — | — | US | disclosed |
| US-5405839-A | Vitamin B12 antagonist; inhibits cell growth; anticancer agents | TEIJIN LIMITED (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0350958-B1 | Improved polyimide and polyimide film and manufacturing method thereof | KANEGAFUCHI CHEMICAL IND (JP) | 1994-12-21 | — | — | EP | disclosed |
| EP-0425680-A1 | NEW VITAMIN B 12? DERIVATIVE, PRODUCTION THEREOF, AND APPLICATION THEREOF | TEIJIN LIMITED (JP) | 1991-05-08 | — | — | EP | disclosed |
| EP-0350958-A2 | Improved polyimide and polyimide film and manufacturing method thereof | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1990-01-17 | — | — | EP | disclosed |
| EP-0134157-B1 | LAYERED VANADIUM COMPOUNDS CONTAINING PHOSPHORUS OR ARSENIC AND PENDANT ORGANIC GROUPS | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1989-09-27 | — | — | EP | disclosed |
| US-4518534-A | Layered vanadium compounds containing phosphorus or arsenic and pendant organic groups | EXXON RESEARCH & ENGINEERING CO. (US) | 1985-05-21 | — | — | US | disclosed |
| EP-0134157-A2 | Layered vanadium compounds containing phosphorus or arsenic and pendant organic groups | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1985-03-13 | — | — | EP | disclosed |
| US-4276409-A | USED FOR CHELATING METALLIC IONS | OCCIDENTAL RESEARCH CORPORATION (US) | 1981-06-30 | — | — | US | disclosed |
| US-4276411-A | SUPPORTS FOR CHROMATOGRAPHY, MOLECULAR SIEVES, ION EXCHANGERS | OCCIDENTAL RESEARCH CORPORATION (US) | 1981-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010037032-A1 | Polyunsaturated fatty acid derivatives and their use | RXRA, RXRB, LPAR2 | ALDH1A1 650/4885TDP1 1383/4885 |
| US-20160030321-A1 | CALCIUM SEQUESTRATION COMPOSITIONS AND METHODS OF TREATING SKIN PIGMENTATION DISORDERS AND CONDITIONS | S100A4, TYR, CACYBP | ALDH1A1 2945/4885TDP1 2370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.